Jumei Zeng

6PUBLICATIONS
14CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBioprocessing, bioproduction and bioproductsCancer diagnosisInfectious agentsMicrobial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 09, 2026
Design, Synthesis, and Antitubercular Activity Evaluation of Novel Nitroimidazole Derivatives.

|Dec 19, 2025
[Advances in Novel Disinfection Technologies for Biofilm-Associated Nosocomial Infections].

Donghui Ke, Xingyan Tan, Kun Chen

|Dec 13, 2023
Discovery and Mechanistic Study of Novel <i>Mycobacterium tuberculosis</i> ClpP1P2 Inhibitors.

Yang Yang, Ninglin Zhao, Xin Xu

|Aug 04, 2022
Discovery and Mechanistic Study of <i>Mycobacterium tuberculosis</i> PafA Inhibitors.

Cong Li, Song Liu, Baoyu Dong

|Apr 08, 2020
Protein kinases PknA and PknB independently and coordinately regulate essential Mycobacterium tuberculosis physiologies and antimicrobial susceptibility.

Jumei Zeng, John Platig, Tan-Yun Cheng

|Jul 12, 2019
Toxin-mediated ribosome stalling reprograms the Mycobacterium tuberculosis proteome.

Valdir C Barth, Ju-Mei Zeng, Irina O Vvedenskaya

Pageof 1

Frequent Collaborators

2 joint publications

Youfu Luo

1 joint publications

Valdir C Barth

1 joint publications

Irina O Vvedenskaya

1 joint publications

Ming Ouyang